Her seminar, titled "Differential Roles of NADPH Oxidases in Vascular Function," will take place Feb. 3, 2011, at 3:30 p.m. in the Medical Sciences Building auditorium on USA’s main campus.
Dr. Griending’s research is focused on the role of NADPH oxidases (Nox) in vascular biology and disease. Her laboratory uses molecular techniques to study the subunit structure of Nox enzymes and their downstream targets. Dr. Griendling has a particular interest in how reactive oxygen species (ROS) derived from these enzymes regulate the signaling pathways leading to smooth muscle proliferation, migration and differentiation.
In 2005, Dr. Griendling became the vice chair for faculty development in the department of medicine at Emory University. She has trained 28 post-doctoral fellows, many of whom have gone on to have successful academic careers. She is a fellow of the American Heart Association and a member of the graduate faculty in molecular and systems pharmacology.
Dr. Griendling received her Ph.D. in cardiovascular physiology from Johns Hopkins University in 1982 and completed postdoctoral training at the University of Pennsylvania and Harvard University.
She serves as an associate editor for Circulation Research and The American Journal of Physiology-Cell Physiology. In addition, she is one of the executive editors of Antioxidants and Redox Signaling.
For more information on Dr. Griendling’s research, visit http://medicine.emory.edu/divisions/cardiology/faculty/griendling_bio.cfm
For additional information on the lecture, contact Natalie Kent at (251) 461-1548.
